Noul Co

Noul Co Enterprise Value

The Enterprise Value (EV) of Noul Co (376930.KQ) as of Oct 31, 2026 is 93.50 B KRW. In the previous year, Enterprise Value (EV) was 83.17 B KRW — a change of 12.43% (higher).

Enterprise Value

93.50 BKRW

YoY

12.43%

Last updated:

Enterprise Value (EV) of Noul Co is 2025 93.50 B KRW. Enterprise Value (EV) of Noul Co was 2024 83.17 B KRW. It decreases by 12.43% higher compared to the previous year.

The Noul Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
93.95 B KRW
Jan 1, 2020
92.21 B KRW
Jan 1, 2021
87.42 B KRW
Jan 1, 2022
92.69 B KRW
Jan 1, 2023
80.67 B KRW
Jan 1, 2024
83.17 B KRW
Jan 1, 2025
93.50 B KRW
The Noul Co Enterprise Value history
YEAREnterprise ValueYoY
93.50 BKRW+12.43%
83.17 BKRW+3.09%
80.67 BKRW-12.96%
92.69 BKRW+6.03%
87.42 BKRW-5.20%
92.21 BKRW-1.85%
93.95 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Noul Co Stock analysis

What does Noul Co do? Noul Co., Ltd. generates revenue through the manufacture and sale of blood test diagnostic devices utilizing AI algorithms and diagnostic kits. The company offers regular monthly subscriptions via its integrated web-based remote diagnosis system, targeting healthcare providers and medical facilities seeking advanced diagnostic solutions. Its core products include AI-based diagnostic devices and associated kits, sold directly to clinics and hospitals for use in blood testing procedures. The firm's services are designed to enhance diagnostic accuracy and efficiency through remote access and subscription models. The company's primary revenue streams stem from the sale of physical diagnostic devices and diagnostic kits, alongside recurring subscription fees for its web-based remote diagnosis platform. Healthcare institutions and medical professionals form the key customer segments, purchasing both the hardware and ongoing service access. Noul Co., Ltd. focuses on delivering AI-driven diagnostic tools that integrate seamlessly into existing healthcare workflows, emphasizing convenience and technological innovation for its clients. Noul Co., Ltd. operates exclusively within the healthcare diagnostics sector, providing AI-powered blood test solutions that combine hardware sales with subscription-based software services. The business model relies on initial device purchases followed by continuous revenue from monthly subscriptions, creating a sustainable income stream. This approach ensures long-term engagement with healthcare providers while maintaining a focus on cutting-edge diagnostic technology. Noul Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Noul Co stock

Enterprise Value (EV) of Noul Co is 93.50 B KRW in 2025.

Enterprise Value (EV) of Noul Co changed from 83.17 B KRW to 93.50 B KRW, representing a 12.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Noul Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s KRW, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' KRW varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Noul Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Noul Co

All Key Metrics — Noul Co